At a $418M market cap, the market is pricing LSAK like a stressed, low-expectation turnaround despite a Forward P/E of 13.9 and an exceptionally low PEG Forward of 0.3, which screams growth-adjusted undervaluation. However, the Altman Z-Score of 2.2 places it in the grey zone—neither distressed nor safe—while an Operating Margin of -18.40% and ROIC of -5.70% confirm that capital is currently being deployed inefficiently. The valuation multiples (0.6x sales, 1.6x book) imply skepticism, but the Piotroski F-Score of 7 signals improving internal fundamentals. This is not a clean compounder—it’s a financially strained operator trading at a compressed multiple where execution will determine whether the low PEG is a gift or a trap.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.